imatinib mesylate has been researched along with Central Nervous System Tuberculosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, SK; Kumar, N; Tripathi, AK; Verma, SP | 1 |
1 other study(ies) available for imatinib mesylate and Central Nervous System Tuberculosis
| Article | Year |
|---|---|
Case reports of chronic myeloid leukemia and tuberculosis: Is imatinib the link between the two?
Topics: Adult; Antineoplastic Agents, Immunological; Causality; Dasatinib; Drug Substitution; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mycobacterium tuberculosis; Pleural Effusion; Protein Kinase Inhibitors; Treatment Outcome; Tuberculosis, Central Nervous System; Tuberculosis, Pleural | 2021 |